» Articles » PMID: 16048978

First Nosocomial Outbreak of Pseudomonas Aeruginosa Producing an Integron-borne Metallo-beta-lactamase (VIM-2) in the United States

Overview
Specialty Pharmacology
Date 2005 Jul 29
PMID 16048978
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Carbapenemases are rare in the United States. This is the first report of a United States nosocomial outbreak of pan-resistant Pseudomonas aeruginosa infections due to an integron-borne metallo-beta-lactamase, VIM-2. This emergence of carbapenemases on mobile genetic elements in the United States warrants surveillance.

Citing Articles

Difficult-to-treat (DTR) harboring Verona-Integron metallo-β-lactamase (): infection management and molecular analysis.

Vega A, DeRonde K, Jimenez A, Piazza M, Vu C, Martinez O Antimicrob Agents Chemother. 2024; 68(5):e0147423.

PMID: 38602418 PMC: 11064525. DOI: 10.1128/aac.01474-23.


Genetic Factors That Contribute to Antibiotic Resistance through Intrinsic and Acquired Bacterial Genes in Urinary Tract Infections.

Harris M, Fasolino T, Ivankovic D, Davis N, Brownlee N Microorganisms. 2023; 11(6).

PMID: 37374909 PMC: 10300863. DOI: 10.3390/microorganisms11061407.


Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors.

Czobor Barbu I, Gheorghe-Barbu I, Grigore G, Vrancianu C, Chifiriuc M Int J Mol Sci. 2023; 24(9).

PMID: 37175597 PMC: 10178704. DOI: 10.3390/ijms24097892.


The First Swedish Outbreak with VIM-2-Producing , Occurring between 2006 and 2007, Was Probably Due to Contaminated Hospital Sinks.

Fraenkel C, Starlander G, Tano E, Sutterlin S, Melhus A Microorganisms. 2023; 11(4).

PMID: 37110397 PMC: 10143745. DOI: 10.3390/microorganisms11040974.


Co-existence of VIM-2-producing and KPC-2 and OXA-232-co-producing in the United States.

Palavecino E, Ramirez K, Greene S, Kilic A Ann Lab Med. 2019; 40(3):267-269.

PMID: 31858769 PMC: 6933063. DOI: 10.3343/alm.2020.40.3.267.


References
1.
Cornaglia G, Mazzariol A, Lauretti L, Rossolini G, Fontana R . Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin Infect Dis. 2000; 31(5):1119-25. DOI: 10.1086/317448. View

2.
Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

3.
Gibb A, Tribuddharat C, Moore R, Louie T, Krulicki W, Livermore D . Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7). Antimicrob Agents Chemother. 2001; 46(1):255-8. PMC: 126979. DOI: 10.1128/AAC.46.1.255-258.2002. View

4.
Bellais S, Mimoz O, Leotard S, Jacolot A, Petitjean O, Nordmann P . Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002; 46(6):2032-4. PMC: 127240. DOI: 10.1128/AAC.46.6.2032-2034.2002. View

5.
Poirel L, Nordmann P . Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr Pharm Biotechnol. 2002; 3(2):117-27. DOI: 10.2174/1389201023378427. View